Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 503

1.

Usefulness of preimplantation B-type natriuretic peptide level for predicting response to cardiac resynchronization therapy.

Lellouche N, De Diego C, Cesario DA, Vaseghi M, Horowitz BN, Mahajan A, Wiener I, Boyle NG, Fonarow GC, Shivkumar K.

Am J Cardiol. 2007 Jan 15;99(2):242-6. Epub 2006 Nov 20.

PMID:
17223426
[PubMed - indexed for MEDLINE]
2.

Usefulness of brain natriuretic peptide level at implant in predicting mortality in patients with advanced but stable heart failure receiving cardiac resynchronization therapy.

El-Saed A, Voigt A, Shalaby A.

Clin Cardiol. 2009 Nov;32(11):E33-8. doi: 10.1002/clc.20490.

PMID:
19816874
[PubMed - indexed for MEDLINE]
3.

Left ventricular apical wall motion abnormality is associated with lack of response to cardiac resynchronization therapy in patients with ischemic cardiomyopathy.

Buch E, Lellouche N, De Diego C, Vaseghi M, Cesario DA, Fujimura O, Wiener I, Child JS, Boyle NG, Shivkumar K.

Heart Rhythm. 2007 Oct;4(10):1300-5. Epub 2007 Jul 14.

PMID:
17905335
[PubMed - indexed for MEDLINE]
4.

Left ventricular resynchronization is mandatory for response to cardiac resynchronization therapy: analysis in patients with echocardiographic evidence of left ventricular dyssynchrony at baseline.

Bleeker GB, Mollema SA, Holman ER, Van de Veire N, Ypenburg C, Boersma E, van der Wall EE, Schalij MJ, Bax JJ.

Circulation. 2007 Sep 25;116(13):1440-8. Epub 2007 Sep 4.

PMID:
17785624
[PubMed - indexed for MEDLINE]
Free Article
5.

Brain natriuretic peptide levels and response to cardiac resynchronization therapy in heart failure patients.

Delgado RM, Palanichamy N, Radovancevic R, Vrtovec B, Radovancevic B.

Congest Heart Fail. 2006 Sep-Oct;12(5):250-3. Erratum in: Congest Heart Fail. 2006 Nov-Dec;12(6):342. Vrtotec, Bojan [corrected to Vrtovec, Bojan].

PMID:
17033272
[PubMed - indexed for MEDLINE]
6.

Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.

Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P, van der Wall EE, Schalij MJ.

J Am Coll Cardiol. 2004 Nov 2;44(9):1834-40.

PMID:
15519016
[PubMed - indexed for MEDLINE]
Free Article
7.

Changes and predictive value of dispersion of repolarization parameters for appropriate therapy in patients with biventricular implantable cardioverter-defibrillators.

Lellouche N, De Diego C, Akopyan G, Boyle NG, Mahajan A, Cesario DA, Wiener I, Shivkumar K.

Heart Rhythm. 2007 Oct;4(10):1274-83. Epub 2007 Jun 16.

PMID:
17905332
[PubMed - indexed for MEDLINE]
8.

Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.

Ding LG, Hua W, Zhang S, Chu JM, Chen KP, Wang Y, Wang FZ, Chen X.

Chin Med J (Engl). 2009 Mar 20;122(6):617-21.

PMID:
19323922
[PubMed - indexed for MEDLINE]
Free Article
9.

Usefulness of QRS duration to predict response to cardiac resynchronization therapy in patients with end-stage heart failure.

Mollema SA, Bleeker GB, van der Wall EE, Schalij MJ, Bax JJ.

Am J Cardiol. 2007 Dec 1;100(11):1665-70. Epub 2007 Oct 24.

PMID:
18036366
[PubMed - indexed for MEDLINE]
10.

Myocardial gene expression in heart failure patients treated with cardiac resynchronization therapy responders versus nonresponders.

Vanderheyden M, Mullens W, Delrue L, Goethals M, de Bruyne B, Wijns W, Geelen P, Verstreken S, Wellens F, Bartunek J.

J Am Coll Cardiol. 2008 Jan 15;51(2):129-36. doi: 10.1016/j.jacc.2007.07.087.

PMID:
18191736
[PubMed - indexed for MEDLINE]
Free Article
11.

Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure.

Van Bommel RJ, Ypenburg C, Borleffs CJ, Delgado V, Marsan NA, Bertini M, Holman ER, Schalij MJ, Bax JJ.

Am J Cardiol. 2010 Apr 15;105(8):1153-8. doi: 10.1016/j.amjcard.2009.12.018. Epub 2010 Feb 20.

PMID:
20381669
[PubMed - indexed for MEDLINE]
12.

Prediction of cardiac resynchronization therapy response: value of calibrated integrated backscatter imaging.

Bertini M, Delgado V, den Uijl DW, Nucifora G, Ng AC, van Bommel RJ, Borleffs CJ, Boriani G, Schalij MJ, Bax JJ.

Circ Cardiovasc Imaging. 2010 Jan;3(1):86-93. doi: 10.1161/CIRCIMAGING.109.882324. Epub 2009 Nov 17.

PMID:
19920028
[PubMed - indexed for MEDLINE]
Free Article
13.

Prognostic value of plasma brain natriuretic peptide, urea nitrogen, and creatinine in outpatients >70 years of age with heart failure.

Feola M, Aspromonte N, Canali C, Ceci V, Giovinazzo P, Milani L, Quarta G, Ricci R, Scardovi AB, Uslenghi E, Valle R.

Am J Cardiol. 2005 Sep 1;96(5):705-9.

PMID:
16125500
[PubMed - indexed for MEDLINE]
14.

Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial.

Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, Canby RC, Schroeder JS, Liem LB, Hall S, Wheelan K; Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLE ICD) Trial Investigators.

JAMA. 2003 May 28;289(20):2685-94.

PMID:
12771115
[PubMed - indexed for MEDLINE]
15.

Value of brain natriuretic peptide after acute myocardial infarction.

Güneş Y, Okçün B, Kavlak E, Erbaş C, Karcier S.

Anadolu Kardiyol Derg. 2008 Jun;8(3):182-7.

PMID:
18524723
[PubMed - indexed for MEDLINE]
Free Article
16.

Prognostic value of electrocardiographic measurements before and after cardiac resynchronization device implantation in patients with heart failure due to ischemic or nonischemic cardiomyopathy.

Iler MA, Hu T, Ayyagari S, Callahan TD 4th, Civello KC, Thal SG, Wilkoff BL, Chung MK.

Am J Cardiol. 2008 Feb 1;101(3):359-63. doi: 10.1016/j.amjcard.2007.08.043. Epub 2007 Dec 21.

PMID:
18237600
[PubMed - indexed for MEDLINE]
17.

Improvement of serum NT-ProBNP predicts improvement in cardiac function and favorable prognosis after cardiac resynchronization therapy for heart failure.

Yu CM, Fung JW, Zhang Q, Chan CK, Chan I, Chan YS, Kong SL, Sanderson JE, Lam CW.

J Card Fail. 2005 Jun;11(5 Suppl):S42-6.

PMID:
15948100
[PubMed - indexed for MEDLINE]
18.

High sensitivity C-reactive protein predicts nonresponders and cardiac deaths in severe heart failure patients after CRT implantation.

Kamioka M, Suzuki H, Yamada S, Kamiyama Y, Saitoh S, Takeishi Y.

Int Heart J. 2012;53(5):306-12.

PMID:
23038092
[PubMed - indexed for MEDLINE]
Free Article
19.

Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.

Herweg B, Ilercil A, Cutro R, Dewhurst R, Krishnan S, Weston M, Barold SS.

Am J Cardiol. 2007 Jul 1;100(1):90-3. Epub 2007 May 15.

PMID:
17599447
[PubMed - indexed for MEDLINE]
20.

Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.

Cleland J, Freemantle N, Ghio S, Fruhwald F, Shankar A, Marijanowski M, Verboven Y, Tavazzi L.

J Am Coll Cardiol. 2008 Aug 5;52(6):438-45. doi: 10.1016/j.jacc.2008.04.036.

PMID:
18672164
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk